A. Golec

发表

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine

I. Sermet-Gaudelus, A. Edelman, A. Hinzpeter, 2019, Front. Pharmacol..

Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters

S. Marullo, I. Guerrera, I. Sermet-Gaudelus, 2022, International journal of molecular sciences.

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849 + 10 kb C-to-T splicing mutation

B. Kerem, L. Carmel, E. Kerem, 2021, bioRxiv.

Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis

L. Touqui, J. Sallenave, X. Nassif, 2019, Scientific Reports.

Keratin 8 is a scaffolding and regulatory protein of ERAD complexes

J. Irving, D. Lomas, G. Lukács, 2022, Cellular and Molecular Life Sciences.

Modulators of CFTR. Updates on clinical development and future directions.

I. Sermet-Gaudelus, M. Semeraro, C. Gravier-Pelletier, 2021, European journal of medicinal chemistry.

Phenotypical and ultrastructural features of Oct4-positive cells in the adult mouse lung

W. Seeger, R. Voswinckel, R. Morty, 2014, Journal of cellular and molecular medicine.

Correlating genotype with phenotype using CFTR‐mediated whole‐cell Cl− currents in human nasal epithelial cells

I. Sermet-Gaudelus, N. Servel, D. Sheppard, 2021, The Journal of physiology.

Isolation, cultivation, and application of primary respiratory epithelial cells obtained by nasal brushing, polyp samples, or lung explants

I. Sermet, D. Downey, L. Galietta, 2022, STAR Protocols.

Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.

B. Kerem, P. Reix, P. Burgel, 2023, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The H 2 S-generating enzymes cystathionine (cid:2) -synthase and cystathionine (cid:3) lyase play a role in vascular development during normal lung alveolarization

W. Seeger, F. Reichenberger, K. Mayer, 2015 .